4.7 Review

Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD-A Systematic Review and Meta-analysis

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis

Michael H. Le et al.

Summary: This study aimed to determine the global and regional prevalence trends of NAFLD. The results showed that the overall prevalence of NAFLD is increasing, despite regional variations. South America and North America have the highest prevalence rates. The study suggests that policy makers should increase awareness of NAFLD and promote healthy lifestyle environments to reverse this trend.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank

Daljeet Chahal et al.

Summary: This study compared lean NAFLD and overweight or obese NAFLD and found that they have distinct features. A risk score was developed, incorporating both clinical and genetic factors, which accurately classifies lean NAFLD patients and could serve as a screening tool.

HEPATOLOGY INTERNATIONAL (2022)

Article Gastroenterology & Hepatology

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

Ramy Younes et al.

Summary: Lean Caucasian subjects with NAFLD may progress to advanced liver disease, develop metabolic comorbidities, and experience cardiovascular disease and liver-related mortality, independent of longitudinal progression to obesity and PNPLA3 genotype. These patients represent one end of a wide spectrum of phenotypic expression of NAFLD.
Review Gastroenterology & Hepatology

A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease

Jonathan Zhi Kai Toh et al.

Summary: This study aims to explore the association between coronary heart disease (CHD) and nonalcoholic fatty liver disease (NAFLD) by investigating the global prevalence, independent risk factors, and influence of steatosis grade on manifestation of CHD among patients with NAFLD.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Endocrinology & Metabolism

A clinical overview of non-alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications-What the non-specialist needs to know

Mark D. Muthiah et al.

Summary: This article discusses the spectrum of disease, common presentations, and management of non-alcoholic fatty liver disease (NAFLD), as well as considerations for managing cardiovascular comorbidities and screening in high-risk populations.

DIABETES OBESITY & METABOLISM (2022)

Article Gastroenterology & Hepatology

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease

Yuna Kim et al.

Summary: Lean NAFLD patients have a significantly higher ASCVD score and prevalence of high risk for ASCVD compared to obese NAFLD patients and non-NAFLD patients. Additionally, lean subjects with significant liver fibrosis have a higher probability of ASCVD than obese subjects within the NAFLD subpopulation.

GUT AND LIVER (2022)

Review Endocrinology & Metabolism

Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals

Jingxuan Quek et al.

Summary: MAFLD significantly increases the risk of cardiovascular diseases and mortality, as well as various systemic diseases such as stroke and chronic kidney disease.

ENDOCRINE PRACTICE (2022)

Article Gastroenterology & Hepatology

Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?

Zobair M. Younossi et al.

Summary: This study compared the long-term outcomes of NAFLD and MAFLD and found that they have similar clinical profiles and long-term prognosis. Insulin resistance is a predictor of liver mortality in NAFLD, while alcohol-associated liver disease (ALD) is the primary driver of mortality in MAFLD.

HEPATOLOGY (2022)

Review Oncology

Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis

Darren Jun Hao Tan et al.

Summary: Compared with hepatocellular carcinoma due to other causes, patients with NAFLD-related hepatocellular carcinoma are older, have higher BMI, and are more likely to have metabolic comorbidities and cardiovascular disease. The surveillance rate is lower, but the proportion of patients without cirrhosis is higher.

LANCET ONCOLOGY (2022)

Article Clinical Neurology

Tenets for the Proper Conduct and Use of Meta-Analyses: A Practical Guide for Neurosurgeons

Keng Siang Lee et al.

Summary: Neurosurgeons are overwhelmed with research publications, leading to an increased popularity of systematic reviews and meta-analyses. While well-executed meta-analyses can provide valuable insights for clinical practice, recent audits have found deficiencies in methodologic rigor and adherence to guidelines in neurosurgery research. These deficiencies can be addressed through better awareness and adherence to standards, but there are also inherent problems and unique constraints in the field that require unconventional techniques to overcome.

WORLD NEUROSURGERY (2022)

Letter Gastroenterology & Hepatology

Global multi-stakeholder endorsement of the MAFLD definition

Nahum Mendez-Sanchez et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals

Ansel Shao Pin Tang et al.

Summary: This meta-analysis shows that the progressive increase of steatosis in NAFLD significantly increases the risk of carotid atherosclerosis and stroke development. More than a third of the patients suffered from carotid atherosclerosis, highlighting the quintessential role of routine assessment of carotid atherosclerosis in NAFLD.

CLINICAL AND MOLECULAR HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases

Ethan M. Weinberg et al.

Summary: More than 10% of NAFLD patients in the United States are lean, with Asians accounting for almost half of them. Lean patients have lower prevalence of cirrhosis, CVD, and metabolic abnormalities compared to non-lean patients. Asian participants have significantly lower prevalence of these conditions than non-Asians across all BMI categories.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

From NAFLD to MAFLD: Implications of a Premature Change in Terminology

Zobair M. Younossi et al.

Summary: The article discusses the proposal to rename NAFLD to MAFLD, highlighting the shortcomings of the new term and warning that changing the name without a comprehensive understanding may have negative implications for the field. The recommendation is to establish a true international consensus group to assess the impact and consequences of the terminology change and make recommendations based on available evidence to move the field forward.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Clinical profile of non-alcoholic fatty liver disease in nonobese patients

Johnathan Huey Ming Lum et al.

Summary: Obese and nonobese patients have similar risks of NASH and advanced fibrosis in NAFLD. Obese patients are typically younger and more likely to have diabetes, while nonobese patients are harder to diagnose with advanced fibrosis.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Endocrinology & Metabolism

Lean non-alcoholic fatty liver disease and risk of incident diabetes in a euglycaemic population undergoing health check-ups: A cohort study

Limin Wei et al.

Summary: The study found that lean NAFLD is associated with an increased risk of incident diabetes, especially more pronounced in women than in men. Further investigations are needed to better understand the natural history of NAFLD in lean subjects.

DIABETES & METABOLISM (2021)

Article Cardiac & Cardiovascular Systems

The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study

Wen Dai et al.

Summary: The study found that non-obese NAFLD is an independent risk factor for T2D in non-obese individuals, but did not observe a significant association with incident CAD.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Medicine, General & Internal

Application of a Novel Prediction Model for Predicting 2-Year Risk of Non-Alcoholic Fatty Liver Disease in the Non-Obese Population with Normal Blood Lipid Levels: A Large Prospective Cohort Study from China

Liwei Ji et al.

Summary: This study developed and validated a nomogram to predict the 2-year risk of NAFLD in non-obese individuals with normal blood lipid levels. The nomogram showed high predictive accuracy and clinical utility based on various indicators and analysis methods.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)

Article Physiology

Lean non-alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross-sectional study

Yasir Mohammed Khayyat

Summary: A study in Saudi Arabia found that lean NAFLD patients displayed features of metabolic syndrome, including elevated glycosylated hemoglobin and abnormal lipid profile, but with higher serum HDL compared to other weight categories.

PHYSIOLOGICAL REPORTS (2021)

Article Gastroenterology & Hepatology

Nonalcoholic Fatty Liver in Lean Individuals: Clinicobiochemical Correlates of Histopathology in 157 Liver Biopsies from Healthy Liver Donors

Narendra S. Choudhary et al.

Summary: In this study, it was found that 33.7% of lean living donors had nonalcoholic fatty liver (NAFL). Among all metabolic risk factors, only higher triglyceride levels showed a significant association with NAFL in lean donors.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Comparison of clinical and metabolic profiles of lean versus non-lean nonalcoholic fatty liver disease

Ann Margaret C. Navarroza et al.

Summary: The study compared the clinical and biochemical profiles of lean and non-lean NAFLD patients. Non-lean patients were younger and more likely to have diabetes, hypertension, dyslipidemia, and metabolic syndrome, as well as abnormal metabolic parameters and elevated liver enzymes, compared to lean patients.

INDIAN JOURNAL OF GASTROENTEROLOGY (2021)

Review Gastroenterology & Hepatology

Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

Daniel Q. Huang et al.

Summary: The prevalence of NAFLD-related HCC is projected to continue rising globally, with NASH expected to increase and obesity as a major risk factor. Urgent measures are needed to address this growing problem.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease

Michihiro Iwaki et al.

Summary: This study compared the gut microbiota composition in non-obese and obese patients with non-alcoholic fatty liver disease and found significant differences in Eubacterium abundance and butyric acid levels. However, there were no significant differences in alpha diversity between these groups. The decrease in Eubacterium abundance in non-obese individuals may play a crucial role in the development of non-alcoholic fatty liver disease.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Nutrition & Dietetics

Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals

Huajie Dai et al.

Summary: The study found that the ratio of fat mass to fat-free mass (FM/FFM) significantly influenced the risk of non-alcoholic fatty liver disease (NAFLD) and fibrosis in both non-obese and obese individuals, with different factors potentially mediating the association between body composition and NAFLD risk according to obesity status.

NUTRITION & METABOLISM (2021)

Article Gastroenterology & Hepatology

The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study

Ping-Fang Hu et al.

Summary: The prevalence of NAFLD increases with age and waist circumference, and nonobese female NAFLD patients have a higher risk of metabolic diseases compared to obese subjects without NAFLD.

HEPATOBILIARY SURGERY AND NUTRITION (2021)

Article Endocrinology & Metabolism

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)

Yifang Li et al.

Summary: Compared to obese individuals, the incidence of NAFLD is lower in non-obese populations and more common in males. The peak age of NAFLD occurrence in non-obese males is also delayed.BMI and triglycerides should still be controlled to prevent NAFLD even in those with normal BMI.

DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2021)

Article Gastroenterology & Hepatology

Visceral adiposity as a risk factor for lean non-alcoholic fatty liver disease in potential living liver donors

Sunyoung Lee et al.

Summary: The severity of non-alcoholic fatty liver was positively correlated with visceral fat accumulation in a lean Asian population. Visceral adiposity may be a risk factor for lean NAFLD in potential living liver donors.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Liver-related Mortality is Increased in Lean Subjects with Non-alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects

Alexandra Feldman et al.

Summary: Lean subjects with NAFLD have distinctive clinical features compared to obese individuals, with a higher risk of liver-related death and increased fibrosis. Clinical follow-up for lean NAFLD subjects is essential for early detection and management of liver-related complications.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2021)

Article Nutrition & Dietetics

Independent Dose-Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease

Chia-Wen Lu et al.

Summary: Lean NAFLD patients have higher levels of fetuin-A, while non-lean NAFLD patients do not show a significant association with fetuin-A levels. This suggests a specific association between fetuin-A and lean NAFLD.

NUTRIENTS (2021)

Article Primary Health Care

Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center

Khalid A. Alsuhaibani et al.

Summary: The study revealed a strong correlation between high cholesterol and LDL levels with lean fatty liver patients, as well as a higher risk of fatty liver development in females. Liver enzymes were within normal ranges, except for GGT which was elevated in all groups, indicating insensitivity in diagnosing fatty liver patients.

JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2021)

Review Gastroenterology & Hepatology

Value of Visceral Fat Area and Resting Energy Expenditure in Assessment of Metabolic Characteristics in Obese and Lean Nonalcoholic Fatty Liver Disease

Qing Ye et al.

Summary: The study demonstrates that NAFLD patients suffer from nutritional imbalances and energy metabolic abnormalities, regardless of whether obesity is present. Certain indicators may be higher in lean NAFLD patients, such as LDL and UA, while some indicators may change in obese NAFLD patients, such as CHO% and FAT%.

TURKISH JOURNAL OF GASTROENTEROLOGY (2021)

Article Medicine, General & Internal

Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis

Jee-Fu Huang et al.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2020)

Letter Gastroenterology & Hepatology

Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease

Charmaine Fu et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation

Fei Chen et al.

HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid

Ahad Eshraghian et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Role of intensive dietary and lifestyle interventions in the treatment of lean nonalcoholic fatty liver disease patients

Pinar Hamurcu Varol et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Redefining non-alcoholic fatty liver disease: what's in a name?

[Anonymous]

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Burden of Disease due to Nonalcoholic Fatty Liver Disease

Mark D. Muthiah et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)

Review Gastroenterology & Hepatology

NAFLD as a driver of chronic kidney disease

Christopher D. Byrne et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Associations between obesity and metabolic health with nonalcoholic fatty liver disease in elderly Chinese

Li-Ming Wu et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2020)

Article Endocrinology & Metabolism

Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults

Ya-Nan Zhang et al.

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)

Article Gastroenterology & Hepatology

Clinical and anthropometric characteristics of non-obese non-alcoholic fatty liver disease subjects in Japan

Takashi Shida et al.

HEPATOLOGY RESEARCH (2020)

Review Gastroenterology & Hepatology

Global epidemiology of lean non-alcoholic fatty liver disease: A systematic review and meta-analysis

Feng-Bin Lu et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Cardiac & Cardiovascular Systems

The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study

Ehimen C. Aneni et al.

AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)

Article Gastroenterology & Hepatology

Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity

Nirmalya Sinha et al.

INDIAN JOURNAL OF GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Both WHR and FLI as Better Algorithms for Both Lean and Overweight/Obese NAFLD in a Chinese Population

Chunlong Li et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2019)

Article Cardiac & Cardiovascular Systems

Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese

K-C Sung et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2019)

Article Endocrinology & Metabolism

Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution

Louise Johanna Maria Alferink et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2019)

Article Gastroenterology & Hepatology

Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup

Chiao-Lin Hsu et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)

Review Gastroenterology & Hepatology

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

Zobair M. Younossi et al.

JOURNAL OF HEPATOLOGY (2019)

Article Endocrinology & Metabolism

Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study

Dong Hyun Sinn et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)

Article Gastroenterology & Hepatology

Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign

Maki Tobari et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Non-alcoholic fatty liver disease in lean individuals

Somaya Albhaisi et al.

JHEP REPORTS (2019)

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects

Soon Sun Kim et al.

DIGESTIVE AND LIVER DISEASE (2018)

Article Gastroenterology & Hepatology

Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population

Shou-Wu Lee et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)

Article Neurosciences

The Influence of Abdominal and Ectopic Fat Accumulation on Carotid Intima-Media Thickness: A Chongqing Study

Xu Yi et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)

Article Neurosciences

The Influence of Abdominal and Ectopic Fat Accumulation on Carotid Intima-Media Thickness: A Chongqing Study

Xu Yi et al.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)

Article

Fixed and random effects models: making an informed choice

Andrew Bell et al.

QUALITY & QUANTITY (2018)

Article Medicine, General & Internal

Association of Body Mass Index With Blood Pressure Among 1.7 Million Chinese Adults

George C. Linderman et al.

JAMA NETWORK OPEN (2018)

Article Gastroenterology & Hepatology

Histological Severity and Clinical Outcomes of Nonalcoholic Fatty Liver Disease in Nonobese Patients

Jonathan Chung-Fai Leung et al.

HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity

Anna Ludovica Fracanzani et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors

Yasushi Honda et al.

HEPATOLOGY RESEARCH (2016)

Article Endocrinology & Metabolism

RELATIVE CONTRIBUTIONS OF ECTOPIC LIVER AND ABDOMINAL FAT ACCUMULATION TO ARTERIAL STIFFNESS

Zhi Xiao Luo et al.

ENDOCRINE PRACTICE (2015)

Article Obstetrics & Gynecology

Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index

Zhongli Wang et al.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2015)

Article Gastroenterology & Hepatology

Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012

Kenichi Nishioji et al.

JOURNAL OF GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels

Umit Akyuz et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)

Article Health Care Sciences & Services

Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness

Catalin Tufanaru et al.

INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)

Article Health Care Sciences & Services

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Xiang Wan et al.

BMC MEDICAL RESEARCH METHODOLOGY (2014)

Article Gastroenterology & Hepatology

379 Characteristics and Long-Term Prognosis of Lean Patients With Nonalcoholic Fatty Liver Disease

Anna Christina Dela Cruz et al.

GASTROENTEROLOGY (2014)

Article Primary Health Care

The Impact of Weight Changes on Nonalcoholic Fatty Liver Disease in Adult Men with Normal Weight

Ji-Young Cho et al.

KOREAN JOURNAL OF FAMILY MEDICINE (2014)

Review Health Care Sciences & Services

The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence

Zachary Munn et al.

INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2014)

Article Gastroenterology & Hepatology

The Severity of Histologic Liver Lesions Is Independent of Body Mass Index in Patients With Nonalcoholic Fatty Liver Disease

Aikaterini Margariti et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)

Article Medicine, General & Internal

Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States

Zobair M. Younossi et al.

MEDICINE (2012)

Review Gastroenterology & Hepatology

Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications

Elisa Fabbrini et al.

HEPATOLOGY (2010)

Article Medicine, General & Internal

What is heterogeneity and is it important?

John Fletcher

BMJ-BRITISH MEDICAL JOURNAL (2007)

Article Gastroenterology & Hepatology

Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics

K Omagari et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)